POLD4 and neoplasm: POLD4 was reported to participate in DNA replication and repair to sustain tumor cell survival (40), and in our study, the transcriptomics analysis indicated that it led to poor prognosis of NSCLC patients, however, the proteomics analysis revealed that it was a protective factor in LUSC.